Related Experiment Video

Updated: Oct 12, 2025

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
08:57

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Published on: March 26, 2015

27.3K

[Interest of doxycycline sclerodesis in Morel-Lavallée lesion]

E Meriglier1, A Chrétien2, S Bencheikh3

  • 1Service de Médecine Interne et Post-Urgence, Hôpital Pellegrin, CHU Bordeaux, place Amélie Raba Léon, 33000 Bordeaux, France; Université de Bordeaux, Bordeaux, France.

La Revue De Medecine Interne
|November 20, 2021
PubMed
Abstract

No abstract available in PubMed .

Keywords:
DoxycyclineMorel-Lavallée lesionSclerotherapySclérothérapieSyndrome de Morel-Lavallée

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.6K
A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice04:55

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice

Published on: May 11, 2022

4.2K

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
63